The trademark application DHANIMAV was filed by Kiniksa Pharmaceuticals, Ltd., a corporation established under the laws of "BM" (the "Applicant"). The application was published for oppositions on March 8, 2022, and it was registered by office on June 15, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on January 10, 2023.